Project VerioVue Enhancements - Arterial Study - Trial NCT06121856
Access comprehensive clinical trial information for NCT06121856 through Pure Global AI's free database. This phase not specified trial is sponsored by LifeScan Scotland Ltd and is currently Completed. The study focuses on Diabetes Mellitus. Target enrollment is 116 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
LifeScan Scotland Ltd
Timeline & Enrollment
N/A
Feb 07, 2023
Apr 28, 2023
Primary Outcome
Performance evaluation: blood glucose monitoring system accuracy: BGMS vs reference instrument using arterial blood
Summary
The aim of this performance evaluation is to compare the blood glucose results obtained using
 the VerioVue Blood Glucose Monitoring System (BGMS) with those obtained from a validated
 comparator method (iSTAT 1 Analyser) using arterial blood. The main question the study aims
 to answer is:
 
 How accurate is the VerioVue BGMS when compared to a product that has already been confirmed
 as accurate (iSTAT 1 Analyser) when hospital staff test arterial blood on these two types of
 instrument? Participants will have a small amount of blood taken from an existing arterial
 line.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06121856
Device Trial